The World Health Organization has finally granted Covaxin an emergency use listing. Covaxin is India's indigenous COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).
Technical Advisory Group, convened by WHO & made up of regulatory experts from around the world, has determined that Covaxin vaccine meets WHO standards for protection against COVID, that benefit of the vaccine far outweighs risks & the vaccine can be used across the world:
The covaxin vaccine was also reviewed by WHOβs Strategic Advisory Group of Experts on Immunization (SAGE), and recommended use of this vaccine in two doses, with a dose interval of four weeks, in all age groups 18 and above:
The approval means that the vaccine will be recognised by other countries and those vaccinated by covaxin will not be required for self-quarantine or face restrictions when travelling abroad.
The emergency listing, or EUL, comes at the end of a lengthy and rigorous review period - manufacturers Bharat Biotech first applied in April and provided required data in July - that involves assurances about the vaccine's safety, efficacy and stability, as well as checks of production facilities.
π 24 Apr, 2025 10:17 PM
8th Pay Commission likely to be set up by mid May
π 09 Apr, 2025 10:27 AM
Loan EMIs to get Cheaper as RBI cuts Repo Rate sgain | See the benefit
π 04 Apr, 2025 04:49 PM
AICPI-IW declines again, may affect DA hike in July 2025
π 04 Apr, 2025 04:46 PM
NPS To UPS Switch from April 1: A Detailed Look at the Option to Switch
π 27 Mar, 2025 10:25 PM
7th CPC wanted a permanent pay panel, end DA revision twice
π 27 Mar, 2025 08:43 AM
8th Pay Commission: What Kind Of Salary Hike Can Be Staff Expected?
π 20 Mar, 2025 08:24 AM
Why the commuted pension is restored after 15 years, not 12 years
π 17 Mar, 2025 08:37 AM
π Expected Dearness Allowance (DA) from January 2026 Calculator